首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >Derivatization of (+/-)-5-((2-methylphenoxy)methyl)-2-amino-2-oxazoline, an imidazoline binding sites ligand, with (+)-(R)-alpha-methylbenzyl isocyanate for drug monitoring purposes.
【24h】

Derivatization of (+/-)-5-((2-methylphenoxy)methyl)-2-amino-2-oxazoline, an imidazoline binding sites ligand, with (+)-(R)-alpha-methylbenzyl isocyanate for drug monitoring purposes.

机译:咪唑啉结合位点配体(+/-)-5-((2-甲基苯氧基)甲基)-2-氨基-2-恶唑啉与(+)-(R)-α-甲基苄基异氰酸酯的衍生化,用于药物监测。

获取原文
获取原文并翻译 | 示例

摘要

The derivatization of racemic 5-[(2-methylphenoxy)methyl]-2-amino-2-oxazoline, developed as an imidazoline binding sites ligand, with (+)-(R)-alpha-methylbenzyl isocyanate was performed in chloroform. The reaction led to two pairs of diastereomers, which were separated by RP-HPLC. A kinetic study of the derivatization reaction was achieved in order to establish conditions suitable for experimental drug monitoring.
机译:在氯仿中用(+)-(R)-α-甲基苄基异氰酸酯衍生化为咪唑啉结合位点配体的外消旋5-[[(2-甲基苯氧基)甲基] -2-氨基-2-恶唑啉。反应产生两对非对映异构体,其通过RP-HPLC分离。为了建立适用于实验药物监测的条件,对衍生化反应进行了动力学研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号